KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $55.6 million.

  • Charles River Laboratories International's Income from Continuing Operations fell 20.97% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 118.60%. This contributed to the annual value of $25.3 million for FY2024, which is 94.74% down from last year.
  • Per Charles River Laboratories International's latest filing, its Income from Continuing Operations stood at $55.6 million for Q3 2025, which was up 5.43% from $52.7 million recorded in Q2 2025.
  • Charles River Laboratories International's Income from Continuing Operations' 5-year high stood at $189.1 million during Q4 2022, with a 5-year trough of -$213.7 million in Q4 2024.
  • Its 3-year average for Income from Continuing Operations is $58.2 million, with a median of $74.5 million in 2024.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 48.94% in 2022, then crashed by 213.12% in 2024.
  • Charles River Laboratories International's Income from Continuing Operations (Quarterly) stood at $139.8 million in 2021, then surged by 35.24% to $189.1 million in 2022, then dropped by 0.08% to $189.0 million in 2023, then plummeted by 213.12% to -$213.7 million in 2024, then declined by 20.97% to $55.6 million in 2025.
  • Its last three reported values are $55.6 million in Q3 2025, $52.7 million for Q2 2025, and $25.9 million during Q1 2025.